observational study

Estimands in Observational Studies

Ever wondered about the intricate connections between observational studies and the Estimand framework in the pharmaceutical industry? How do the challenges in multi-country primary data collection unfold, and what crucial role do assumptions play in propensity score methods? In this captivating episode, I’m excited to have Artemis Koukounari, an accomplished statistician and associate director in real-world evidence at Novartis, join me for an insightful conversation. Join us as we explore these questions and more, unraveling the complexities of real-world evidence and offering a glimpse into the future of data research in the pharmaceutical realm. We also discuss the following key points:

By country analyses for clinical trials and observational studies

How could differences between countries affect the elements that are included in statistical research? How could studies with such a diverse sample from different countries be managed to create a more dependable reference for statistical studies? How do differences of the quality of care that the target population receives impact studies? As statisticians, we need to be able to understand the validity of the outcomes of statistical analysis for different target populations.  In this podcast, you will learn ways to tackle this problem: